Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Ben A van Hout"'
Publikováno v:
PLoS ONE, Vol 5, Iss 7, p e11562 (2010)
BACKGROUND: The costs and benefits of controlling nosocomial spread of antibiotic-resistant bacteria are unknown. METHODS: We developed a mathematical algorithm to determine cost-effectiveness of infection control programs and explored the dynamical
Externí odkaz:
https://doaj.org/article/ed2798d1ea48430795f5ecf3c0cef262
Autor:
Marjanne A. Piena, Sonja Kroep, Claire Simons, Elisabeth Fenwick, Gerard T. Harty, Schiffon L. Wong, Ben A. van Hout
Publikováno v:
Adv Ther
An innovative computational model was developed to address challenges regarding the evaluation of treatment sequences in patients with relapsing-remitting multiple sclerosis (RRMS) through the concept of a 'virtual' physician who observes and assesse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae0db2cbf760d318f2c94560105a45ab
https://europepmc.org/articles/PMC9172692/
https://europepmc.org/articles/PMC9172692/
Autor:
Kathelijn Fischer, Maurice E. Pouw, Daniel Lewandowski, Mart P. Janssen, H. Marijke van den Berg, Ben A. van Hout
Publikováno v:
Haematologica, Vol 96, Iss 5 (2011)
Background Severe hemophilia requires life-long treatment with expensive clotting factor concentrates; studies comparing effects of different therapeutic strategies over decades are very difficult to perform. A simulation model was developed to evalu
Externí odkaz:
https://doaj.org/article/aebffc6315f9424ab53d92f2dab06cb7
Publikováno v:
Value in Health, 17(4), 445-453. ELSEVIER SCIENCE INC
OBJECTIVES: To describe the research that has been undertaken by the EuroQol Group to improve current methods for health state valuation, to summarize the results of an extensive international pilot program, and to outline the key elements of the fiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::222de0cec79c1608ccc8fd7478b96474
https://doi.org/10.1016/j.jval.2014.04.002
https://doi.org/10.1016/j.jval.2014.04.002
Publikováno v:
Health Economics
A new version of the EQ‐5D, the EQ‐5D‐5L, is available. The aim of this study is to produce a value set to support use of EQ‐5D‐5L data in decision‐making. The study design followed an international research protocol. Randomly selected me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97840f9f190ef89fabd2dc399a449d3b
https://pubmed.ncbi.nlm.nih.gov/28833869
https://pubmed.ncbi.nlm.nih.gov/28833869
Autor:
You-Shan Feng, Thomas Kohlmann, Andrew B. Lloyd, Dominik Golicki, Mathieu F. Janssen, A. Simon Pickard, Luciana Scalone, Ben A. van Hout, Jan J. Busschbach, Paul Kind
Publikováno v:
Value in Health, 15(5), 708-715. Elsevier Ltd.
Background A five-level version of the EuroQol five-dimensional (EQ-5D) descriptive system (EQ-5D-5L) has been developed, but value sets based on preferences directly elicited from representative general population samples are not yet available. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b112387fbadc221a3d9c1d82ea58dfb2
Autor:
Grahame Wilkinson, Koonal Shah, Carl Tilling, Ben A. van Hout, Aki Tsuchiya, Nancy Devlin, Ken Buckingham
Publikováno v:
Health Economics. 22:517-532
'Lead Time' TTO improves upon conventional TTO by providing a uniform method for eliciting positive and negative values. This research investigates (i) the values generated from different combinations of time in poor health and in full health; and th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::19f7feaa25ef179a4d7a978f44e13051
https://doi.org/10.1002/hec.2819
https://doi.org/10.1002/hec.2819
Publikováno v:
Transfusion. 52:478-488
BACKGROUND: During the past decade, blood screening tests such as triplex nucleic acid amplification testing (NAT) and human T-cell lymphotropic virus type I or I (HTLV-I/II) antibody testing were added to existing serologic testing for hepatitis B v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b4e1864284085d306ef5f89ea3ae37d
https://doi.org/10.1111/j.1537-2995.2011.03319.x
https://doi.org/10.1111/j.1537-2995.2011.03319.x
Publikováno v:
Applied Health Economics and Health Policy. 8(4):251-265
Background: Antiplatelet therapy plays a central role in the prevention of atherothrombotic events. Both acetylsalicylic acid (aspirin) and clopidogrel have been shown to reduce the risk of recurrent cardiovascular events in various subgroups of pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______645::dc989e16ae855e141efd43e995c9ad67
http://healtheconomics.adisonline.com/pt/re/ahe/fulltext.00148365-201008040-00004.htm
http://healtheconomics.adisonline.com/pt/re/ahe/fulltext.00148365-201008040-00004.htm
Autor:
Herman van Engeland, Hendrik Koffijberg, Jocelyne A. Posthumus, Maartje A. J. Raaijmakers, Ben A. van Hout, Walter Matthys
Publikováno v:
Contemporary clinical trials, 29(2), 293-303. Elsevier
Introduction: Randomization is the most optimal design for evaluating program-effectiveness. In practice, however, conducting a randomized controlled trial is not always feasible. For a non-randomized study into the effect of a parent management trai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1427d6ee5c689bd5dfe4403a04a6a9c9
https://doi.org/10.1016/j.cct.2007.07.006
https://doi.org/10.1016/j.cct.2007.07.006